Concepedia

Yu‐Ke Fu

YF

4

Publications

108

Citations

4

H-Index

2019

Active since

Affiliations

National Health Research Institutes(Current)

China Medical University

Yu‐Ke Fu is an author at National Health Research Institutes specializing in medicine, oncology, and tumor biology.

Top concepts

MedicineOncologyCell BiologyTumor BiologyCancer BiologyCell MigrationTumor MicroenvironmentHealthPathologyCell Death

Publications per year

2019–2025

4

Publications

4

Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference

Yu‐Ke Fu, Bi‐Juan Wang, Jen‐Chih Tseng et al. · Journal of Biomedical Science · 2022 · 42 citations · Full text

LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis

Chang Xu, Jie Zhai, Yu‐Ke Fu · Neoplasma · 2020 · 30 citations · Full text

Gynecology, Cell Death, Pathology +18

ERK Activation Modulates Cancer Stemness and Motility of a Novel Mouse Oral Squamous Cell Carcinoma Cell Line

Yulin Chen, Ko‐Jiunn Liu, Chuan‐Wei Jang et al. · Cancers · 2019 · 25 citations · Full text

Tumor Innervation, Immunology, Immunoediting +18

Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming

Ssu-Han Wang, Yulin Chen, Shih‐Han Huang et al. · Oncogenesis · 2025 · 11 citations · Full text

Rows per page

1–4 of 4